188 related articles for article (PubMed ID: 18187744)
1. Sildenafil improves health-related quality of life in patients with pulmonary arterial hypertension.
Pepke-Zaba J; Gilbert C; Collings L; Brown MC
Chest; 2008 Jan; 133(1):183-9. PubMed ID: 18187744
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil citrate therapy for pulmonary arterial hypertension.
Galiè N; Ghofrani HA; Torbicki A; Barst RJ; Rubin LJ; Badesch D; Fleming T; Parpia T; Burgess G; Branzi A; Grimminger F; Kurzyna M; Simonneau G;
N Engl J Med; 2005 Nov; 353(20):2148-57. PubMed ID: 16291984
[TBL] [Abstract][Full Text] [Related]
3. Oral sildenafil therapy improves health-related quality of life and functional status in pulmonary arterial hypertension.
Wong RC; Koh GM; Choong PH; Yip WL
Int J Cardiol; 2007 Jul; 119(3):400-2. PubMed ID: 17064789
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.
Wilkins MR; Paul GA; Strange JW; Tunariu N; Gin-Sing W; Banya WA; Westwood MA; Stefanidis A; Ng LL; Pennell DJ; Mohiaddin RH; Nihoyannopoulos P; Gibbs JS
Am J Respir Crit Care Med; 2005 Jun; 171(11):1292-7. PubMed ID: 15750042
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
Bharani A; Mathew V; Sahu A; Lunia B
Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
[TBL] [Abstract][Full Text] [Related]
6. Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil.
Gilbert C; Brown MCJ; Cappelleri JC; Carlsson M; McKenna SP
Chest; 2009 Jan; 135(1):137-142. PubMed ID: 18812447
[TBL] [Abstract][Full Text] [Related]
7. [Sildenafil therapy for pulmonary hypertension: a prospective study].
Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zeng WJ; Zhu F; He JG
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):419-23. PubMed ID: 21781512
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.
Sastry BK; Narasimhan C; Reddy NK; Raju BS
J Am Coll Cardiol; 2004 Apr; 43(7):1149-53. PubMed ID: 15063421
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.
Badesch DB; Hill NS; Burgess G; Rubin LJ; Barst RJ; Galiè N; Simonneau G;
J Rheumatol; 2007 Dec; 34(12):2417-22. PubMed ID: 17985403
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs.
Brown AJ; Davison E; Sleeper MM
J Vet Intern Med; 2010; 24(4):850-4. PubMed ID: 20412435
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
[TBL] [Abstract][Full Text] [Related]
13. [Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension].
Sakuma M; Shirato K
Nihon Rinsho; 2008 Nov; 66(11):2157-61. PubMed ID: 19051736
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil therapy for pulmonary arterial hypertension associated with atrial septal defects.
Lim ZS; Salmon AP; Vettukattil JJ; Veldtman GR
Int J Cardiol; 2007 May; 118(2):178-82. PubMed ID: 17027100
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
16. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
[TBL] [Abstract][Full Text] [Related]
18. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
[TBL] [Abstract][Full Text] [Related]
19. Analysis of single items on the Self-Esteem and Relationship questionnaire in men treated with sildenafil citrate for erectile dysfunction: results of two double-blind, placebo-controlled trials.
Cappelleri JC; Althof SE; O'Leary MP; Tseng LJ; ;
BJU Int; 2008 Apr; 101(7):861-6. PubMed ID: 18070194
[TBL] [Abstract][Full Text] [Related]
20. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
